JLK gets FDA OK for prostate cancer diagnosis AI solution
Jeong Min Nam
Jun 25, 2024 (Gmt+09:00)
South Korea’s JLK Inc., an AI-based diagnosis solution and platform maker, announced on Monday that it got approval from the US Food and Drug Administration (FDA) for its prostate cancer diagnostic solution Medihub Prostate.